Results 81 to 90 of about 4,774 (193)

A PROCEDURE FOR THE DETERMINATION OF 4-AMINOSALICYLIC ACID (p-AMINOSALICYLIC ACID) IN BLOOD AND IN URINE

Journal of Biological Chemistry, 1949
D M, TENNENT, M L, LELAND
openaire   +2 more sources

The current consensus on ulcerative colitis, and the evidence and perspectives on the influence of gut microbiota on it. [PDF]

Front Med (Lausanne)
Chen Y, Liu C.
europepmc   +1 more source

Multi-dimensional immunoprotection of Ganoderma lucidum spore oil in immunosuppressed mice via microbiome-proteome-metabolome network analysis. [PDF]

Sci Rep
Deng S, Wu X, Xu W, Wu X, Cai H, Wang S, Liu J, Cao J.   +7 more
europepmc   +1 more source

The role of metabolomics in enhancing diagnosis and management of inflammatory bowel disease: a systematic review. [PDF]

Ther Adv Gastroenterol
Sharkiya SH, Namni R, Wattad O, Abu Baker F.   +3 more
europepmc   +1 more source

Long-Term Ozanimod Therapy in Patients With Moderately Active Ulcerative Colitis After Failure of 5-Aminosalicylic Acid. [PDF]

Inflamm Bowel Dis
Yarur A, Irving P, Siegmund B, Dubinsky MC, Ananthakrishnan AN, Regueiro M, Ungaro RC, Ritter T, Nakase H, Liu Z, Mehra D, Osterman MT, Jain A, Rubin DT, Hibi T.   +14 more
europepmc   +1 more source

Magnetically Recoverable ICT-Functionalized Fe₃O₄ Nanoparticles for Efficient Horseradish Peroxidase Immobilization. [PDF]

Molecules
Isaković K, Jonović M, Sredojević D, Bošković M, Periša J, Knežević-Jugović Z, Lazić V.   +6 more
europepmc   +1 more source

Design, synthesis and exploration of cyclic imides as PDE4 inhibitors in psoriasis. [PDF]

RSC Med Chem
K S V, Panja P, Nath T, Naidu VGM, Sethi KK.   +4 more
europepmc   +1 more source

Study on the role of the combination of quercetin and lutein in alleviating ulcerative colitis in mice. [PDF]

Front Nutr
Xu Z, Mi S, Chitrakar B, Wang L, Li Y, Shi R, Sang Y, Yu W, Wang X.   +8 more
europepmc   +1 more source

Current and emerging therapies for pulmonary tuberculosis in adults. [PDF]

BMJ Med
Mahmood A, Ashfaq MB, Drain C, Melby E, Hunter M, Shaw TD.   +5 more
europepmc   +1 more source

Mirikizumab: a landmark in IL-23-targeted therapy for ulcerative colitis. [PDF]

Ann Med Surg (Lond)
Iqbal MU, Shafquat E, Khan MO, Abu Nahla U.   +3 more
europepmc   +1 more source